AI, Analytics and Big Data AI as strategist: Integrating human intuition with AI analysis Feb, 2026 | Article Joshua Gans The future of strategic leadership lies not in choosing between human intuition and AI analysis, but in designing organizational structures that effectively integrate both. AI, Analytics and Big Data Automation versus augmentation: What will AI's lasting impact on jobs be? Jul, 2024 | Article Avi Goldfarb Joshua Gans Ajay Agarwal Evidence is mounting that AI will have the greatest impact on tasks performed by high-wage workers — and will provide new opportunities for those at the lower end of the scale. AI, Analytics and Big Data How should we deal with copyright and AI? Jul, 2024 | Opinion Joshua Gans A battle is brewing between content creators and artificial intelligence firms: Copyright can protect a creator's work, but also hinder the tech's advancement. Professor Joshua Gans proposes a better strategy for navigating this new reality. AI, Analytics and Big Data AI could fundamentally change the way systems are built...if we let it Nov, 2022 | Book Ajay Agrawal Avi Goldfarb Joshua Gans Everything is built on systems of constraint, and until we revisit the rules that glue these systems together, AI will only ever add incremental value. Healthcare and Life Sciences Study shows low incident of false positive results from rapid antigen yests Jan, 2022 | Article Ajay Agrawal Avi Goldfarb Joshua Gans Sonia Sennik Janice Gross Stein Laura Rosella Concerned about the accuracy of your COVID antigen test? Turns out you shouldn't be. The rates of a false positive on the rapid antigen tests are low, according to a major new study led by the Creative Destruction Lab Rapid Screening Consortium. Finance, Investing and Accounting Preparing for COVID-29 Sep, 2021 | Article Joshua Gans With COVID-19, multiple failures in obtaining and applying the right information to key decisions led to economic and social calamity, says professor Joshua Gans. For potential COVID-29s, we need to do better. Economics, Trade and Policy The Pandemic Information Solution explains why knowledge is our most powerful tool in overcoming this crisis Apr, 2021 | Book Joshua Gans Rotman professor Joshua Gans’ latest book is a worthwhile read for those curious about the bigger questions surrounding COVID-19 and the economy. Healthcare and Life Sciences COVID-19 isn’t going away — what leaders need to know Mar, 2021 | Opinion Joshua Gans Accepting that COVID-19 will become endemic, always with us, will help put focus on developing new treatments and ways to scale up testing as needed. Previous 1 2 3 Next
AI, Analytics and Big Data Automation versus augmentation: What will AI's lasting impact on jobs be? Jul, 2024 | Article Avi Goldfarb Joshua Gans Ajay Agarwal Evidence is mounting that AI will have the greatest impact on tasks performed by high-wage workers — and will provide new opportunities for those at the lower end of the scale. AI, Analytics and Big Data How should we deal with copyright and AI? Jul, 2024 | Opinion Joshua Gans A battle is brewing between content creators and artificial intelligence firms: Copyright can protect a creator's work, but also hinder the tech's advancement. Professor Joshua Gans proposes a better strategy for navigating this new reality. AI, Analytics and Big Data AI could fundamentally change the way systems are built...if we let it Nov, 2022 | Book Ajay Agrawal Avi Goldfarb Joshua Gans Everything is built on systems of constraint, and until we revisit the rules that glue these systems together, AI will only ever add incremental value. Healthcare and Life Sciences Study shows low incident of false positive results from rapid antigen yests Jan, 2022 | Article Ajay Agrawal Avi Goldfarb Joshua Gans Sonia Sennik Janice Gross Stein Laura Rosella Concerned about the accuracy of your COVID antigen test? Turns out you shouldn't be. The rates of a false positive on the rapid antigen tests are low, according to a major new study led by the Creative Destruction Lab Rapid Screening Consortium. Finance, Investing and Accounting Preparing for COVID-29 Sep, 2021 | Article Joshua Gans With COVID-19, multiple failures in obtaining and applying the right information to key decisions led to economic and social calamity, says professor Joshua Gans. For potential COVID-29s, we need to do better. Economics, Trade and Policy The Pandemic Information Solution explains why knowledge is our most powerful tool in overcoming this crisis Apr, 2021 | Book Joshua Gans Rotman professor Joshua Gans’ latest book is a worthwhile read for those curious about the bigger questions surrounding COVID-19 and the economy. Healthcare and Life Sciences COVID-19 isn’t going away — what leaders need to know Mar, 2021 | Opinion Joshua Gans Accepting that COVID-19 will become endemic, always with us, will help put focus on developing new treatments and ways to scale up testing as needed. Previous 1 2 3 Next
AI, Analytics and Big Data How should we deal with copyright and AI? Jul, 2024 | Opinion Joshua Gans A battle is brewing between content creators and artificial intelligence firms: Copyright can protect a creator's work, but also hinder the tech's advancement. Professor Joshua Gans proposes a better strategy for navigating this new reality. AI, Analytics and Big Data AI could fundamentally change the way systems are built...if we let it Nov, 2022 | Book Ajay Agrawal Avi Goldfarb Joshua Gans Everything is built on systems of constraint, and until we revisit the rules that glue these systems together, AI will only ever add incremental value. Healthcare and Life Sciences Study shows low incident of false positive results from rapid antigen yests Jan, 2022 | Article Ajay Agrawal Avi Goldfarb Joshua Gans Sonia Sennik Janice Gross Stein Laura Rosella Concerned about the accuracy of your COVID antigen test? Turns out you shouldn't be. The rates of a false positive on the rapid antigen tests are low, according to a major new study led by the Creative Destruction Lab Rapid Screening Consortium. Finance, Investing and Accounting Preparing for COVID-29 Sep, 2021 | Article Joshua Gans With COVID-19, multiple failures in obtaining and applying the right information to key decisions led to economic and social calamity, says professor Joshua Gans. For potential COVID-29s, we need to do better. Economics, Trade and Policy The Pandemic Information Solution explains why knowledge is our most powerful tool in overcoming this crisis Apr, 2021 | Book Joshua Gans Rotman professor Joshua Gans’ latest book is a worthwhile read for those curious about the bigger questions surrounding COVID-19 and the economy. Healthcare and Life Sciences COVID-19 isn’t going away — what leaders need to know Mar, 2021 | Opinion Joshua Gans Accepting that COVID-19 will become endemic, always with us, will help put focus on developing new treatments and ways to scale up testing as needed. Previous 1 2 3 Next
AI, Analytics and Big Data AI could fundamentally change the way systems are built...if we let it Nov, 2022 | Book Ajay Agrawal Avi Goldfarb Joshua Gans Everything is built on systems of constraint, and until we revisit the rules that glue these systems together, AI will only ever add incremental value. Healthcare and Life Sciences Study shows low incident of false positive results from rapid antigen yests Jan, 2022 | Article Ajay Agrawal Avi Goldfarb Joshua Gans Sonia Sennik Janice Gross Stein Laura Rosella Concerned about the accuracy of your COVID antigen test? Turns out you shouldn't be. The rates of a false positive on the rapid antigen tests are low, according to a major new study led by the Creative Destruction Lab Rapid Screening Consortium. Finance, Investing and Accounting Preparing for COVID-29 Sep, 2021 | Article Joshua Gans With COVID-19, multiple failures in obtaining and applying the right information to key decisions led to economic and social calamity, says professor Joshua Gans. For potential COVID-29s, we need to do better. Economics, Trade and Policy The Pandemic Information Solution explains why knowledge is our most powerful tool in overcoming this crisis Apr, 2021 | Book Joshua Gans Rotman professor Joshua Gans’ latest book is a worthwhile read for those curious about the bigger questions surrounding COVID-19 and the economy. Healthcare and Life Sciences COVID-19 isn’t going away — what leaders need to know Mar, 2021 | Opinion Joshua Gans Accepting that COVID-19 will become endemic, always with us, will help put focus on developing new treatments and ways to scale up testing as needed. Previous 1 2 3 Next
Healthcare and Life Sciences Study shows low incident of false positive results from rapid antigen yests Jan, 2022 | Article Ajay Agrawal Avi Goldfarb Joshua Gans Sonia Sennik Janice Gross Stein Laura Rosella Concerned about the accuracy of your COVID antigen test? Turns out you shouldn't be. The rates of a false positive on the rapid antigen tests are low, according to a major new study led by the Creative Destruction Lab Rapid Screening Consortium. Finance, Investing and Accounting Preparing for COVID-29 Sep, 2021 | Article Joshua Gans With COVID-19, multiple failures in obtaining and applying the right information to key decisions led to economic and social calamity, says professor Joshua Gans. For potential COVID-29s, we need to do better. Economics, Trade and Policy The Pandemic Information Solution explains why knowledge is our most powerful tool in overcoming this crisis Apr, 2021 | Book Joshua Gans Rotman professor Joshua Gans’ latest book is a worthwhile read for those curious about the bigger questions surrounding COVID-19 and the economy. Healthcare and Life Sciences COVID-19 isn’t going away — what leaders need to know Mar, 2021 | Opinion Joshua Gans Accepting that COVID-19 will become endemic, always with us, will help put focus on developing new treatments and ways to scale up testing as needed. Previous 1 2 3 Next
Finance, Investing and Accounting Preparing for COVID-29 Sep, 2021 | Article Joshua Gans With COVID-19, multiple failures in obtaining and applying the right information to key decisions led to economic and social calamity, says professor Joshua Gans. For potential COVID-29s, we need to do better. Economics, Trade and Policy The Pandemic Information Solution explains why knowledge is our most powerful tool in overcoming this crisis Apr, 2021 | Book Joshua Gans Rotman professor Joshua Gans’ latest book is a worthwhile read for those curious about the bigger questions surrounding COVID-19 and the economy. Healthcare and Life Sciences COVID-19 isn’t going away — what leaders need to know Mar, 2021 | Opinion Joshua Gans Accepting that COVID-19 will become endemic, always with us, will help put focus on developing new treatments and ways to scale up testing as needed. Previous 1 2 3 Next
Economics, Trade and Policy The Pandemic Information Solution explains why knowledge is our most powerful tool in overcoming this crisis Apr, 2021 | Book Joshua Gans Rotman professor Joshua Gans’ latest book is a worthwhile read for those curious about the bigger questions surrounding COVID-19 and the economy. Healthcare and Life Sciences COVID-19 isn’t going away — what leaders need to know Mar, 2021 | Opinion Joshua Gans Accepting that COVID-19 will become endemic, always with us, will help put focus on developing new treatments and ways to scale up testing as needed. Previous 1 2 3 Next
Healthcare and Life Sciences COVID-19 isn’t going away — what leaders need to know Mar, 2021 | Opinion Joshua Gans Accepting that COVID-19 will become endemic, always with us, will help put focus on developing new treatments and ways to scale up testing as needed. Previous 1 2 3 Next